-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

732A.O2.6 732. Clinical Allogeneic Transplantation: Results: Matched Related, Unrelated, and Alternative Donor Allograft Outcomes for Myeloid and Lymphoid Malignancies

Clinical Allogeneic Transplantation: Results Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 6, 2015: 7:30 AM-9:00 AM
W304, Level 3 (Orange County Convention Center)
Moderators:
Artz Andrew, University of Chicago Medical Center and Johannes Schetelig, MD, M.Sc, University Hospital TU Dresden

Disclosures:
Schetelig: GSK, Sanofi, Janssen, Neovii: Membership on an entity’s Board of Directors or advisory committees , Research Funding .
7:30 AM

Ehab Atallah, MD1, Mary M. Horowitz, MD, MS2, Brent Logan, PhD3*, Min Chen, MS4*, Michael J. Boo, JD5, Corey S Cutler, MD, MPH6, Joachim Deeg, MD7, James L. Gajewski, MD8, Dennis L. Confer, MD5, Stephanie Farnia, MPH5*, Peter Greenberg, MD9, Erica Warlick, MD10, Daniel Weisdorf, MD11 and J. Douglas Rizzo, MD12

1Department of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
2CIBMTR (Center for International Blood & Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
3Division of biostatistics, Medical College of Wisconsin, Milwuakee, WI
4CIBMTR, Medical college of Wisconsin, milwaukee, WI
5National Marrow Donor Program, Minneapolis, MN
6Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
7Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
8Fox Chase Temple BMT Program, Philadelphia, PA
9Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
10University of Minnesota, Minneapolis, MN
11Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
12Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI

7:45 AM

Alberto Mussetti, MD1*, Abraham Sebastian Kanate, MD2, Mohamed A Kharfan-Dabaja, MD3, Kwang Woo Ahn, PhD4*, Alyssa DiGilio, MS4*, Stefan O Ciurea, MD5, Philippe Armand, MD, PhD6, Rachel B. Salit, MD7, Timothy S. Fenske, MD, MS8*, Sonali M. Smith, MD9, Anna Sureda, MD, PhD10*, Javier Bolanos-Meade, MD11* and Mehdi Hamadani, MD12

1S.C. Ematologia e Trapianto Midollo Osseo, Instituto Nazionale Tumori, Milan, Italy
2Osborn Hematopoietic Malignancy and Transplantation Program, Section of Hematology and Oncology; Dept. of Medicine, West Virginia University, Morgantown, WV
3Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Medicine, CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
5M.D. Anderson Cancer Center, Houston, TX
6Dana-Farber Cancer Institute, Boston, MA
7Fred Hutchinson Cancer Research Center, Seattle, WA
8Division of Hematolgy and Oncology, Medical College of Wisconsin, Milwaukee, WI
9University of Chicago, Chicago, IL
10Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
11Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, MD
12Division of Medicine, CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI

8:00 AM

Alice Bertaina, MD, PhD1, Barbarella Lucarelli, MD2*, Riccardo Masetti, MD3*, Pietro Merli, MD2*, Roberto Rondelli, MD4*, Giuseppina Li Pira, PhD2*, Marco Andreani, PhD5*, Lavinia Grapulin, MD6*, Daniela Pende, MD7*, Michela Falco, PhD8*, Maria Rita Pinto, MD2*, Valentina Bertaina, PhD2*, Maria Teresa Romano, MD2*, Stefano Ceccarelli, MD2*, Letizia Pomponia Brescia, MD2*, Daria Pagliara, MD1*, Alessandro Moretta, MD9*, Lorenzo Moretta, MD2* and Franco Locatelli, Prof, MD, PhD1*

1Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
2Ospedale Pediatrico Bambino Gesù, Rome, Italy
3Pediatric Oncology and Hematology, University of Bologna, Bologna, Italy
4Sant'Orsola Hospital, University of Bologna, Bologna, Italy
5Fondazione IME, Rome, Italy
6Università La Sapienza, Rome, Italy
7IRCCS AUO San Martino-IST, Genova, Italy
8Giannina Gaslini Hospital, Genova, Italy
9University of Genoa, Genoa, Italy

8:15 AM

Eolia Brissot, MD.PhD1*, Myriam Labopin, MD2*, Matthias Stelljes3, Gerhard Ehninger, MD4, Gernot Stuhler, MD5*, Jurgen Finke, M.D.6, Hans Jochem Kolb, member7, Arnold Ganser, M.D.8, Kerstin Schaefer-Eckart, MD9, Nicolaus Kroeger, MD10, Donald Bunjes, MD11*, Stephan Mielke, MD12, Wolfgang Bethge, MD13*, Reza Tabrizi, MD14, Kalhs Peter15*, Igor W Blau, MD, PhD16*, Bertran Glass17*, Antonin Vitek18*, Martin Gramatzki, MD19, Ernst Holler, PhD20*, Christoph Schmid21*, Jordi Esteve22, Arnon Nagler, MD, MSc23 and Mohamad Mohty, MD, PhD24

1Service d’Hématologie et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France
2Department of Hematology and Cell Therapy, Saint Antoine Hospital, Paris, France
3Department of Medicine A/Hematology and Oncology, University of Münster, Münster, Germany
4Medical Dept. 1, University Hospital TU Dresden, Dresden, Germany
5Zentrum für Blutstammzell- und Knochenmarktransplantation, DKD Helios Klinik Wiesbaden, Wiesbaden, Germany
6Hematology, Oncology and Stem Cell Transplantation, University of Freiburg, Freiburg, Germany
7Dept for Hematopoetic Transplantations, MED3, University of Munich, Munich, Germany
8Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
9Department of Hematology and Oncology, Klinikum Nuernberg, Nuernberg, Germany
10Department of Stem Cell Transplantation, University Hospital of Hamburg, Hamburg, Germany
11Department of Internal Medicine III, University of Ulm, Ulm, Germany
12Zentrum Innere Medizin (ZIM), Abteilung Hämatologie und Onkologie, Universitätsklinikum Würzburg, Wurzburg, Germany
13Department of Hematology and Oncology, University of Tuebingen, Tuebingen, Germany
14Hematology, University Hospital of Bordeaux, Pessac, France
15Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, vienna, Austria
16Department of Internal Medicine III, Charité Campus Benjamin Franklin, Berlin, Germany
172AsklepiosKlinik St. Georg, AbteilungHämatologie und Stammzelltransplantation, Hambourg, Germany
18Dept. of Hematology, Institute of Hematology and Blood Transfusion, PRAGUE, Czech Republic
19Department of Medicine, University Hospital Schleswig-Holstein Division of Stem Cell Transplantation and Immunotherapy, Kiel, Germany
20Abteilung Hamatologie/Intern.Onkologie, Klinikum der Universitat Regensburg, Regensburg, Germany
212. Medizinische Klinik, Klinikum Augsburg, Augsburg, Germany
22Hospital Clinic de Barcelona, Spanish MDS Cooperative Group, Barcelona, Spain
23Chaim Sheba Medical center and EBMT Acute Leukemia Working Party, Tel-Hashomer and Paris, Israel
24Hematology Department, Saint-Antoine Hospital, AP-HP, Universite Pierre et Marie Curie, Paris, France

8:30 AM

Timothy S. Fenske, MD, MS1*, Tara M. Graff, DO2*, Kwang Woo Ahn, PhD3,4*, Alyssa DiGilio, MS5*, Sonali M. Smith, MD6, Anna Sureda, MD, PhD7* and Mehdi Hamadani, MD8

1Division of Hematolgy and Oncology, Medical College of Wisconsin, Milwaukee, WI
2Medical Oncology Hematology Associates, Des Moines, IA
3CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
4Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI
5Department of Medicine, CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
6University of Chicago, Chicago, IL
7Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
8Division of Medicine, CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI

8:45 AM

Anna Sureda, MD, PhD1*, Mei-Jie Zhang, PhD2,3*, Peter Dreger, MD4,5, Jeanette Carreras, MPH6*, Timothy S. Fenske, MD7, Herve Finel8*, Harry C. Schouten9, Silvia Montoto, MD10, Stephen Robinson11*, Sonali M. Smith, MD12, Ariane Boumendil, PhD13*, Mehdi Hamadani, MD14 and Marcelo C. Pasquini, MD15

1Hematology Department, Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain
2Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI
3CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
4EBMT Lymphoma Working Party, Paris, France
5Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
6Center for International Blood & Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
7Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
8Hopital Saint Antoine, EBMT Paris Study Office, Paris, France
9Department of Internal Medicine - Hematology, Maastricht University Medical Center, Maastricht, Netherlands
10St. Bartholomew`s and The Royal London NHS Trust, London, United Kingdom
11Bristol Oncology Centre, Bristol, United Kingdom
12University of Chicago, Chicago, IL
13EBMT Paris study office / CEREST-TC, Paris, France
14Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
15Medicine, Medical College of Wisconsin, Milwaukee, WI

*signifies non-member of ASH